Anna L. Frongia
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Upper limb motor function in individuals with SMA type 2: natural history and impact of therapies.
Journal: Journal of neurology
Published: March 06, 2025
Communicative development inventory in type 1 and presymptomatic infants with spinal muscular atrophy: a cohort study.
Journal: Archives of disease in childhood
Published: November 11, 2023
Nusinersen efficacy data for 24-month in type 2 and 3 spinal muscular atrophy.
Journal: Annals of clinical and translational neurology
Published: December 30, 2021
Nusinersen in pediatric and adult patients with type III spinal muscular atrophy.
Journal: Annals of clinical and translational neurology
Published: May 03, 2021
Age related treatment effect in type II Spinal Muscular Atrophy pediatric patients treated with nusinersen.
Journal: Neuromuscular disorders : NMD
Published: February 01, 2021
Different trajectories in upper limb and gross motor function in spinal muscular atrophy.
Journal: Muscle & nerve
Published: January 31, 2021
Sometimes they come back: New and old spinal muscular atrophy adults in the era of nusinersen.
Journal: European journal of neurology
Published: September 03, 2020
A critical review of patient and parent caregiver oriented tools to assess health-related quality of life, activity of daily living and caregiver burden in spinal muscular atrophy.
Journal: Neuromuscular disorders : NMD
Published: May 16, 2019
Long-term progression in type II spinal muscular atrophy: A retrospective observational study.
Journal: Neurology
Published: February 28, 2019
Salbutamol tolerability and efficacy in patients with spinal muscular atrophy type II.
Journal: Neuromuscular disorders : NMD
Published: July 07, 2018
Distribution and genotype-phenotype correlation of GDAP1 mutations in Spain.
Journal: Scientific reports
Published: April 12, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026